Avi B. Markowitz - Concepedia

Author

Avi B. Markowitz

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A B Markowitz, A MARKOWITZ, A Markowitz, A. B. Markowitz, A. MARKOWITZ, A. Markowitz, A.B. Markowitz, AVI B. MARKOWITZ, Avi B Markowitz, Avi B. Markowitz

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Medical Branch at Galveston Sunnybrook Health Science Centre Amgen (United States)Hôtel-Dieu de Québec

About

Avi B. Markowitz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	826
2	Health Sciences	5	5	277
3	Cell Biology	2	2	259
4	Head And Neck Surgery	1	1	161
5	Hepatology	1	1	39

Avi B. Markowitz

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. Janice P. Dutcher, Stephen P. Creekmore, Geoffrey R. Weiss, Journal of Clinical Oncology Lak CellsImmunologyImmunoeditingPhase Ii StudyImmunologic Mechanism	1989	236
Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. Richard Pazdur, Yvonne Lassere, Verna A. Rhodes, Journal of Clinical Oncology	1994	206
Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer David J. Vaughn, Catherine M. Broome, Maha Hussain, Journal of Clinical Oncology UrologyOncologyPhase Ii TrialGenitourinary CancerUrothelial Cancer	2002	193
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial Michael Henke, A. Fortin, Heikki Minn, The Lancet Oncology Open-label Phase 2Radiation TherapyNeoadjuvant TherapyMedicineAdvanced Squamous-cell Carcinoma	2015	161
Collecting Duct Carcinoma of the Kidney Meletios Α. Dimopoulos, C. Logothetis, Avi B. Markowitz, British Journal of Urology	1993	139
Surgery Following Response to Interfergn-α-Baseb Therapy for Residual Renal Cell Carcinoma Avishay Sella, David A. Swanson, Jae Y. Ro, The Journal of Urology UrologySurgical OncologyViable TumorGenitourinary CancerMedicine	1993	84
Granulocyte‐macrophage colony‐stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma Meir Wetzler, Zeev Estrov, Moshe Talpaz, Journal of Internal Medicine	1993	52
Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer. L Danhauser, J. H. Freimann, T. L. Gilchrist, Journal of Clinical Oncology	1993	39
Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction Paul J. Schilling, J. Lee Murray, Avi B. Markowitz Cancer ImmunologyPathologyCell DeathOxidative StressInflammation	1992	39
A phase II, randomized trial (CONCERT-1) of chemoradiotherapy (CRT) with or without panitumumab (pmab) in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (LASCCHN). J. Giralt, A. Fortin, Heikki Minn, Journal of Clinical Oncology Phase IiRadiation TherapySquamous Cell CarcinomaMedicineHealth Sciences	2012	33

Page 1